Rosacea Treatment: A Phenotype-Based Approach
The recommended treatment for rosacea should follow a phenotype-based approach targeting specific features rather than subtypes, often requiring combination therapy to address multiple symptoms simultaneously. 1
Treatment Algorithm Based on Clinical Features
First-Line Topical Treatments
For inflammatory lesions (papules/pustules):
For persistent erythema:
First-Line Procedural Options
Systemic Treatment Options
- For moderate to severe papulopustular rosacea:
Treatment by Disease Severity
Mild Rosacea
Moderate Rosacea
Severe Rosacea
Ocular Rosacea Management
Mild symptoms:
Moderate to severe symptoms:
Important Clinical Considerations
Treatment Duration
- Allow 6-12 weeks before determining treatment failure 1
- Inadequate trial periods (less than 8 weeks) may not demonstrate true efficacy 1
Combination Therapy
- Multiple features often coexist and require simultaneous treatment with multiple agents 1
- Monotherapy rarely addresses all rosacea manifestations 1
- Consider combining oral and topical treatments for better outcomes 4
Adverse Effects and Precautions
- With azelaic acid, temporary skin irritation (pruritus, burning, stinging) may occur, especially on broken skin 5
- If irritation persists with azelaic acid, reduce application frequency or discontinue 5
- The 40mg modified-release doxycycline formulation is preferred to reduce antibiotic resistance concerns 1
Long-term Management
- Use the minimum treatment necessary to maintain control 1
- Consider maintenance therapy after achieving control of symptoms 6
- Patient education about trigger avoidance is essential 7
Treatment Efficacy
- Topical antimicrobials and oral antibiotics achieve complete or partial response in approximately 90% of ocular rosacea cases 3
- Intense pulsed light shows 89% partial response rate for ocular symptoms 3
- Combination treatments achieve a complete or partial response in 90% of cases 3
The phenotype-based approach to rosacea management represents a significant advancement over the traditional subtype-based treatment, allowing for more personalized and effective therapy targeting the specific manifestations that are most bothersome to the patient 6, 1.